The MarketWatch News Department was not involved in the creation of this content.-- Novel combinatorial oral therapy extended median remaining lifespan in adult mice by 33% compar ...
SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has launched the next generation of its multi-omics and real-world ...
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial ...
Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...
Cancer metabolism has re-emerged as a central hallmark of tumor initiation, progression, and therapeutic resistance. Advances in high-throughput ...
High-throughput omics technologies transform drug discovery by enabling comprehensive profiling of biological systems and providing insights into disease mechanisms, therapeutic targets, and biomarker ...
EMBL-EBI scientists and collaborators at Heidelberg University have developed CORNETO, a new computational tool that uses machine learning to gain meaningful insights from complex biological data.
A new computational tool helps researchers map molecular interactions, revealing the pathways associated with disease. Understanding how molecules interact inside our cells is key to uncovering how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results